Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via VEGF-C-Reference-Cited by-同舟云学术

Inhibition of Cyclooxygenase-2 Suppresses Lymph Node Metastasis via VEGF-C

Published:2009-10 Issue:10 Volume:292 Page:1577-1583
ISSN:1932-8486
Container-title:The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology
language:en
Short-container-title:Anat Rec

Author:

Liu Huidong,Yang Yanmei,Xiao Jianbing,Lv Yanhong,Liu Yan,Yang Huike,Zhao Linghui

Publisher

Wiley

Subject

Ecology, Evolution, Behavior and Systematics,Histology,Biotechnology,Anatomy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/ar.20940/fullpdf

Reference40 articles.

1. Clinical significance of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in patients with nonsmall cell lung carcinoma;Arinaga;Cancer,2003

2. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan;Banerji;J Cell Biol,1999

3. High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer;Bono;Clin Cancer Res,2004

4. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis;Boolbol;Cancer Res,1996

5. Inhibition of cyclooxygenase-2 suppresses lymph node metastasis via reduction of lymphangiogenesis;Caname;Cancer Res,2007

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment;Biochemical Pharmacology;2021-06

2. Preventing metastasis with pH regulation;An Innovative Approach to Understanding and Treating Cancer: Targeting pH;2020

3. The association of semaphorin 5A with lymph node metastasis and adverse prognosis in cervical cancer;Cancer Cell International;2018-06-22

4. Deciphering Pro-Lymphangiogenic Programs during Mammary Involution and Postpartum Breast Cancer;Frontiers in Oncology;2016-11-02

5. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 “multi-points priming” mechanisms in vitro and in vivo;BMC Cancer;2015-07-19